We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Swp4.0
Saw Palmetto Research
Likely helps
74 peer-reviewed studies
What the evidence says
Likely helps
Saw Palmetto appears to help in 7 of 10 studies with measurable effects — the evidence leans clearly favourable.
Most evidence is from high-quality meta-analyses and randomised trials published 2002–2026 with a typical study size of 225 participants.
Based on 74 studies · 9 meta-analyses · 44 RCTs · 33,876 total participants
Confidence
High confidence
What the studies found
7helped3unclear· 64 more without graded effect data
By outcome
BPH & lower urinary tract symptoms
Likely helps64 studies
Men's vitalityInhibits 5-alpha reductase, but clinical hormonal effect is unproven · 4-12 weeks · Rigorous trials found it no better than placebo for BPH symptoms · 4-8 weeks
Mostly mechanism / observational17 studies
Safety profile
Mostly mechanism / observational15 studies
Therapeutic & clinical
Mostly mechanism / observational9 studies
Skin health
Mostly mechanism / observational7 studies
Women's health
Mostly mechanism / observational3 studies
Inflammation
Too few graded studies2 studies
Heart & blood pressure
Too few graded studies1 study
By the numbers
Pulled from 35 studies with measurable effects
Likely real effects
60%
across studies
People studied
34k
typical study: 225 people
Strongest designs
53
9 pooled, 44 randomised
Showed benefit
70%
7/10 studies
How long studies ran
1–3 months
5
3+ months
4
Populations Studied
Men with BPH7
Men with lower urinary tract symptoms2
Patients with hair loss1
Men with benign prostate hyperplasia1
Active research area
24 studies in the last 5 years · Latest meta-analysis: 2024
200220142026
1Urinary flow rate and nocturiaMeta-Analysisn=5,222 · very large study2018
In plain English: Saw palmetto extract significantly improved urinary flow rate and nocturia compared to placebo in men with BPH.
Vela-Navarrete R et al. · BJU International (2018)
Significant improvement in maximum urinary flow rate vs placebo
Reduced nocturia frequency compared to placebo
Hexanic lipidosterolic extract (Permixon) showed most consistent results
Zong HT, Wang XY, Wang T, Zhou X, Zhang Y · Zhonghua Nan Ke Xue (2019)
No plain-language summary recorded for this citation — open the paper to read its abstract.
6Hair lossSystematic Review2025
In plain English: Natural products such as rosemary, green tea, ginseng, Aloe vera, olive, and saw palmetto have shown promising efficacy in promoting hair growth, improving hair density, reducing hair shedding, and enhancing patient satisfaction through mechanisms involving anti-inflammatory, hormonal, and enhanced scalp circulation.
Allam AT et al. · Naunyn-Schmiedeberg's archives of pharmacology (2025)
However, study design limitations and outcome variability necessitate further rigorous, standardized research.
This review aims to offer an integrative, evidence-informed perspective on the therapeutic potential of herbal medicine for hair loss in clinical evidence.
In plain English: We performed a GRADE evaluation of the quality of evidence for interventions.
McNicholas T et al. · BMJ clinical evidence (2011)
9Prevalence of concurrent prescription drugs and herbal medicinal products useSystematic Review2017
In plain English: The prevalence of concurrent prescription drugs and HMP use among older adults is substantial and potential interactions have been reported.
Agbabiaka TB et al. · Drugs & aging (2017)
No clear effect
← WorseNo effectBetter →
Prevalence of concurrent use by older adults varied widely between 5.3 and 88.3%.
The prevalence of concurrent prescription drugs and HMP use among older adults is substantial and potential interactions have been reported.
Knowledge of the extent and manner in which older adults combine prescription drugs will aid healthcare professionals in appropriately identifying and managing patients at risk.
12quality of lifeReviewn=4,656 · very large study2023
In plain English: Serenoa repens alone provides little to no benefits for men with lower urinary tract symptoms due to benign prostatic enlargement.
Franco JV et al. · The Cochrane database of systematic reviews (2023)
No clear effect
← WorseNo effectBetter →
Serenoa repens results in little to no difference in the quality of life at short-term follow-up (3 to 6 months; IPSS quality of life domain range 0 to 6, higher scores indicate worse quality of life; MD -0.20, 95% CI -0.40 to -0.00; I2 = 39%; 5 studies, 1001 participants; high-certainty evidence).
Serenoa repens probably results in little to no difference in adverse events (1 to 17 months; risk ratio (RR) 1.01, 95% CI 0.77 to 1.31; I2 = 18%; 12 studies, 2399 participants; moderate-certainty evidence).
Serenoa repens results in little to no difference in urologic symptoms at long-term follow-up (12 to 17 months, IPSS score, MD 0.07, 95% CI -0.75 to 0.88; I2 = 34%; 3 studies, 898 participants; high-certainty evidence).
14Herbal medicine drug interactionsSystematic Review2009
In plain English: While the significance of many interactions is uncertain, several interactions, particularly those with St John's wort, may have serious clinical consequences.
Izzo AA et al. · Drugs (2009)
Echinacea might affect the clearance of caffeine (a CYP1A2 probe) and midazolam (a CYP3A4 probe).
No interactions have been reported for saw palmetto (Serenoa repens).
Numerous interactions between herbal medicines and conventional drugs have been documented.
15Systematic review of saw palmetto evidenceSystematic Review2006
In plain English: Here presented is an evidence-based systematic review including written and statistical analysis of scientific literature, expert opinion, folkloric precedent, history, pharmacology, kinetics/dynamics, interactions, adverse effects, toxicology, and dosing.
Ulbricht C et al. · Journal of the Society for Integrative Oncology (2006)
Here presented is an evidence-based systematic review including written and statistical analysis of scientific literature, expert opinion, folkloric precedent, history, pharmacology, kinetics/dynamics, interactions, adverse effects, toxicology, and dosing.
16Adverse events assessmentSystematic Reviewn=26 · very small study2009
In plain English: However, higher quality reporting of adverse events is essential if safety assessments are to be improved in future.
Agbabiaka TB et al. · Drug safety (2009)
Currently available data suggest that S. repens is well tolerated by most users and is not associated with serious adverse events.
The majority of adverse events are mild, infrequent and reversible, and include abdominal pain, diarrhoea, nausea and fatigue, headache, decreased libido and rhinitis.
We found no evidence for drug interactions with S. repens.
17Urinary frequency-related quality of lifeRCTn=34 · small study2025
In plain English: The consumption of SPE improved urinary frequency-related quality of life such as bother of urinary symptoms in healthy Japanese adults (UMIN000045334).
Kimura M et al. · Nutrition and health (2025)
After SPE intervention for 12 weeks, the score of symptom bother by frequent urination during the daytime hours was significantly improved and the daytime frequency of urination assessed using the urinary log was significantly decreased.
The other outcomes were subjective urinary symptoms and urinary frequencies.
The final efficacy analysis dataset was per protocol set, and 33 participants in each group were analyzed.
18Lower urinary tract symptoms (LUTS)RCTn=76 · small study2022
In plain English: In conclusion, the present study is the first to demonstrate the potential of SPE to mitigate LUTS in adult women.
Yamada S et al. · Nutrients (2022)
The daytime frequency of urination in overactive bladder symptom score (OABSS) Q1 was also significantly improved by the SPE treatment.
A subgroup analysis revealed that SPE alleviated the symptoms of daytime frequency (CLSS Q1) and nocturia (CLSS Q2) in a subset of subjects with a CLSS Q5 score of 1 or higher.
In conclusion, the present study is the first to demonstrate the potential of SPE to mitigate LUTS in adult women.
20Treatment assignment blinding successRCTn=151 · medium study2014
In plain English: Blinding of treatment assignment was successful in this study.
Lee JY et al. · Journal of alternative and complementary medicine (New York, N.Y.) (2014)
Could be chance
For participants assigned to saw palmetto, 22.5%, 24.7%, and 29.8% correctly thought they were taking saw palmetto, and 37.3%, 40.0%, and 44.4% incorrectly thought they were on placebo at 24, 48, and 72 weeks, respectively.
For placebo participants, 21.8%, 27.4%, and 25.2% incorrectly thought they were on saw palmetto, and 41.6%, 39.9%, and 42.6% correctly thought they were on placebo at 24, 48, and 72 weeks, respectively.
The treatment arms did not vary with respect to the distributions of participants who guessed they were on saw palmetto (p=0.823) or placebo (p=0.893).